SEC 13F Intelligence

Managers / Q2 2024 · view latest →

Theleme Partners LLP

CIK 0001511881 · 65 CURZON STREET, LONDON, X0, W1J 8PE · 353 607-1800

Reported Value
$2.1B
Q2 2024
Positions
10
Filings on Record
33
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Theleme Partners LLP reported $2.1B in U.S.-listed holdings across 10 positions for Q2 2024.

The portfolio is heavily concentrated: MRNA alone accounts for 35.7% of reported value.

Compared with Q1 2024, the fund opened 1 new position and exited 0.

Portfolio Metrics

Turnover
+4.7%
vs prior filed quarter
Largest Position
+35.7%
Moderna

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $2.0BQ4 ’18Q1 ’19: $1.7BQ2 ’19: $2.1BQ3 ’19: $2.2BQ4 ’19: $1.8BQ4 ’19Q1 ’20: $1.4BQ2 ’20: $2.1BQ3 ’20: $2.2BQ4 ’20: $3.0BQ4 ’20Q1 ’21: $3.0BQ2 ’21: $3.4BQ3 ’21: $3.5BQ4 ’21: $6.0BQ4 ’21Q1 ’22: $6.0BQ2 ’22: $2.5BQ3 ’22: $2.1BQ4 ’22: $2.7BQ4 ’22Q1 ’23: $2.3BQ2 ’23: $2.2BQ3 ’23: $2.0BQ4 ’23: $2.1BQ4 ’23Q1 ’24: $2.0BQ2 ’24: $2.1BQ3 ’24: $1.7BQ4 ’24: $1.5BQ4 ’24Q1 ’25: $1.3BQ2 ’25: $1.6BQ3 ’25: $1.6BQ4 ’25: $1.5BQ4 ’25Q1 ’26: $1.5Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 99.1%ADR: 0.9%
  • Common Stock · 99.1% · $2.1B
  • ADR · 0.9% · $19M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
EFXEQUIFAX INCNEW+391.1K391.1K+$95M$95M
TRUTRANSUNIONADDED+896.0K2.28M+$59M$169M
HDBHDFC BANK LTDADDED+90.0K301.0K+$8M$19M
SKAASKECHERS U S A INCADDED+430.0K1.55M+$39M$107M
HRIHERC HLDGS INCADDED+267.6K1.10M+$7M$146M
WFCWELLS FARGO CO NEWTRIMMED−1.25M4.65M−$66M$276M
MRNAMODERNA INCTRIMMED−1.53M7.23M−$2M$932M
SCHWSCHWAB CHARLES CORPTRIMMED−465.0K4.61M−$27M$339M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

8 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MRNAMODERNA INChistory →COM41.17%$858M7.23M
2SCHWSCHWAB CHARLES CORPhistory →COM16.28%$339M4.61M
3WFCWELLS FARGO CO NEWhistory →COM13.25%$276M4.65M
4TRUTRANSUNIONhistory →COM8.12%$169M2.28M
5HRIHERC HLDGS INChistory →COM7.01%$146M1.10M
6SKAASKECHERS U S A INChistory →CL A5.16%$107M1.55M
7EFXEQUIFAX INChistory →COM4.55%$95M391.1K
8HDBHDFC BANK LTDhistory →SPONSORED ADS0.93%$19M301.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$1.5B10May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$1.5B10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$1.6B11Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$1.6B11Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.3B13May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$1.5B12Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$1.7B12Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.1B10Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.0B10May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$2.1B12Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.0B11Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.2B10Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.3B11May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.7B11Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$2.1B10Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$2.5B12Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$6.0B10May 26, 2022RESTATEMENTchanges · EDGAR ↗
Q4 2021$6.0B11Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.5B8Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$3.4B10Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$3.0B14May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$3.0B17Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$2.2B17Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$2.1B17Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$1.4B16May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.8B7Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.2B11Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$2.1B10Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.7B8May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$2.0B10Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • Theleme Master Fund Ltd028-14311
  • Theleme Special Purpose Fund I LP028-22495

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.